Literature DB >> 20550541

Reduced total testosterone concentrations in young healthy South Asian men are partly explained by increased insulin resistance but not by altered adiposity.

Mousumi Biswas1, David Hampton, Atilla Turkes, Robert G Newcombe, D Aled Rees.   

Abstract

OBJECTIVE: To compare ethnic differences in total, free and bioavailable testosterone amongst young healthy South Asian and Caucasian men. DESIGN AND
SUBJECTS: Cross-sectional study of 134 healthy men (age 20-40 years) of South Asian (n = 67) or Caucasian (n = 67) origin, recruited from hospital staff and students working in Newport, UK. Subjects were excluded if they had a fasting plasma glucose >5.9 mmol/l, central obesity [waist circumference ≥ 94 cm (Caucasian) or ≥ 90 cm (South Asian)] or significant other disease. MEASUREMENTS: Fasting plasma glucose, total testosterone (determined by immunoassay and mass spectrometry), albumin, sex hormone-binding globulin (SHBG) and insulin were measured. Free and bioavailable testosterone were calculated using Vermeulen's formula, and insulin resistance was estimated by HOMA-IR.
RESULTS: The South Asians were slightly older (P = 0.04), shorter (P < 0.001), lighter (P < 0.001), more insulin resistant (P = 0.006), and had a lower body mass index BMI (P = 0.012), waist circumference (P = 0.043) and SHBG (P = 0.001) than the Caucasians. Total testosterone was significantly lower in South Asians (mass spectrometry: geometric mean 16.3 nmol/l; 95% reference interval 9.3-28.6 nmol/l) compared with Caucasians (mass spectrometry: geometric mean 18.4 nmol/l; 95% reference interval 10.6-31.9 nmol/l; P = 0.015), but calculated free and bioavailable testosterone were not different between groups. Adjusting for HOMA-IR, but not BMI or waist circumference, partly attenuated the differences in total testosterone.
CONCLUSIONS: Total, but not free, testosterone concentrations are lower in healthy South Asian men than in Caucasians. These differences are apparent at a young age and may be partly attributable to alterations in insulin sensitivity.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550541     DOI: 10.1111/j.1365-2265.2010.03824.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure.

Authors:  Deborah D Davis; Arnaldo Lopez Ruiz; Licy L Yanes; Radu Iliescu; Kuichang Yuan; Mohadetheh Moulana; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

2.  Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.

Authors:  Johannes D Veldhuis; Olga P Bondar; Roy B Dyer; Sergey A Trushin; Eric W Klee; Ravinder J Singh; George G Klee
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 3.  Androgens and Blood Pressure Control: Sex Differences and Mechanisms.

Authors:  Jane F Reckelhoff
Journal:  Mayo Clin Proc       Date:  2019-01-31       Impact factor: 7.616

4.  Sexual dimorphisms in the associations of BMI and body fat with indices of pubertal development in girls and boys.

Authors:  Melissa K Crocker; Elizabeth A Stern; Nicole M Sedaka; Lauren B Shomaker; Sheila M Brady; Asem H Ali; Thomas H Shawker; Van S Hubbard; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2014-04-29       Impact factor: 5.958

5.  Endogenous sex steroid hormones and glucose in a South-Asian population without diabetes: the Metabolic Syndrome and Atherosclerosis in South-Asians Living in America pilot study.

Authors:  B L Needham; C Kim; B Mukherjee; P Bagchi; F Z Stanczyk; A M Kanaya
Journal:  Diabet Med       Date:  2014-12-11       Impact factor: 4.359

Review 6.  Exploring the role of copy number variants in human adaptation.

Authors:  Rebecca C Iskow; Omer Gokcumen; Charles Lee
Journal:  Trends Genet       Date:  2012-04-05       Impact factor: 11.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.